QS Batterymarch Financial Management’s Alexion Pharmaceuticals ALXN Stock Holding History

QS Batterymarch Financial Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$18.9M	Hold	114,150	–	–	0.5%	40
2014 Q2	$17.8M	Sell	114,150 -26,997	-19%	-$4.26M	0.45%	48
2014 Q1	$21.5M	Sell	141,147 -3,675	-3%	-$584K	0.44%	43
2013 Q4	$19.2M	Buy	144,822 +37,036	+34%	+$4.44M	0.41%	51
2013 Q3	$12.5M	Buy	107,786 +4,880	+5%	+$535K	0.27%	96
2013 Q2	$9.49M	Buy	+102,906	New	+$9.92M	0.18%	151

Other funds holding ALXN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

QS Batterymarch Financial Management's ALXN Position: Q3 2014 in Review

QS Batterymarch Financial Management held its Alexion Pharmaceuticals (ALXN) position steady in Q3 2014 at 114,150 shares worth $18.9M. The position accounts for 0.5% of the portfolio, ranked #40.

QS Batterymarch Financial Management first reported a position in ALXN in Q2 2013 and has held it in 6 quarters since. The position peaked at $21.5M in Q1 2014. 521 funds tracked by Wall St. Rank hold ALXN as of Q3 2014.

QS Batterymarch Financial Management held 114,150 shares of Alexion Pharmaceuticals worth $18.9M as of Q3 2014.
QS Batterymarch Financial Management left its Alexion Pharmaceuticals share count unchanged in Q3 2014.
Alexion Pharmaceuticals made up 0.5% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #40 holding.
QS Batterymarch Financial Management first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
QS Batterymarch Financial Management's Alexion Pharmaceuticals position peaked at $21.5M in Q1 2014.
521 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.